Bill Baer

Bill is Medical Director of Research and Innovation at Mercy Health and Executive Director of VARI-ClinXus, a subsidiary of Mercy Health. He holds multiple faculty appointments, including Associate Professor, at Michigan State University School of Medicine, and an adjunct faculty position in pharmacogenetics at the Van Andel Research Institute. He has received numerous honors and awards and serves in various board/medical director capacities with a number of innovative and forward-thinking organizations including Metagenics, Inc., Metabolic Solutions Development Company, and Hopen Life Science Ventures. He served as co-Chair of the Translational Medicine Working Group for the FDA Critical Paths’ Predictive Safety Testing Consortium. Bill received his MD from West Virginia University School of Medicine and completed his residency at Michigan State University. He received PharmD from West Virginia University and a BS in Pharmacy from Duquesne University. He is a longtime practitioner of internal medicine at Grand Valley Medical Specialists, Grand Rapids, MI.